Evaluation of Metabolic Characteristics Induced by Deoxynivalenol in 3D4/21 Cells

Yu Han1, Bo Yu1, Wenao Weng1

  • 1Laboratory of Genetic Breeding, Reproduction and Precision Livestock Farming & Hubei Provincial Center of Technology Innovation for Domestic Animal Breeding, School of Animal Science and Nutritional Engineering, Wuhan Polytechnic University, Wuhan 430023, China.

Insights

Deoxynivalenol (DON) mycotoxin disrupts pig immune cell metabolism, affecting purine and glutathione pathways. This research identifies key metabolic changes linked to DON-induced immunosuppression in swine.

Area of Science:

  • Veterinary Immunology
  • Toxicology
  • Metabolomics

Background:

  • Deoxynivalenol (DON) is a prevalent mycotoxin causing immunosuppression in pigs.
  • The precise impact of DON on cellular metabolism, particularly in immune cells, is not fully understood.

Purpose of the Study:

  • To investigate metabolic alterations induced by DON in a porcine alveolar macrophage cell line (3D4/21).
  • To elucidate the role of specific metabolic pathways in DON-induced immunotoxicity using a systems biology approach.

Main Methods:

  • Utilized non-targeted metabolomics to analyze metabolic profiles of 3D4/21 cells treated with DON.
  • Employed MTT assays for cell viability assessment and multivariate statistical analyses (PCA, OPLS-DA) for metabolic profiling.
  • Integrated metabolomic data with transcriptomic data to identify key affected pathways.

Main Results:

  • DON exposure reduced cell viability in a dose- and time-dependent manner.
  • Distinct metabolic profiles were observed between control and DON-treated cells, with 127 differential metabolites identified.
  • Key affected pathways included purine metabolism, glutathione metabolism, and arginine-proline metabolism.

Conclusions:

  • DON significantly alters cellular metabolism in porcine immune cells, impacting nucleotide synthesis, energy balance, and antioxidant defense.
  • Disruptions in purine and glutathione metabolism are critical contributors to DON-induced immunotoxicity.
  • These findings offer insights into therapeutic targets for mitigating mycotoxin-related immunosuppression in swine.